{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:24:42Z","timestamp":1793967882018,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.drudis.2023.103806","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T07:28:11Z","timestamp":1698391691000},"page":"103806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Formulation strategies for the development of high drug-loaded amorphous solid dispersions"],"prefix":"10.1016","volume":"28","author":[{"given":"Hemanth","family":"Mamidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Palekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henis","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan Kumar","family":"Nukala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2023.103806_b0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2013.05.061","article-title":"III Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery","volume":"453","author":"Brough","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2023.103806_b0010","doi-asserted-by":"crossref","first-page":"122989","DOI":"10.1016\/j.ijpharm.2023.122989","article-title":"Corroborating various material-sparing techniques with hot melt extrusion for the preparation of triclabendazole amorphous solid dispersions","author":"Palekar","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2023.103806_b0015","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.3390\/pharmaceutics14102203","article-title":"Recent advances in amorphous solid dispersions: preformulation, formulation strategies, technological advancements and characterization","volume":"14","author":"Tambe","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.drudis.2023.103806_b0020","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/acs.molpharmaceut.2c00892","article-title":"Dissolution mechanisms of amorphous solid dispersions: role of drug load and molecular interactions","volume":"20","author":"Deac","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.drudis.2023.103806_b0025","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.molpharmaceut.8b01261","article-title":"Insights into the dissolution mechanism of ritonavir\u2013copovidone amorphous solid dispersions: importance of congruent release for enhanced performance","volume":"16","author":"Indulkar","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.drudis.2023.103806_b0030","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.xphs.2019.02.028","article-title":"Influence of glass forming ability on the physical stability of supersaturated amorphous solid dispersions","volume":"108","author":"Blaabjerg","year":"2019","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.drudis.2023.103806_b0035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejpb.2016.11.031","article-title":"Glass-forming ability of compounds in marketed amorphous drug products","volume":"112","author":"Wyttenbach","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.drudis.2023.103806_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2018.12.002","article-title":"Chemically identical but physically different: a comparison of spray drying, hot melt extrusion and cryo-milling for the formulation of high drug loaded amorphous solid dispersions of naproxen","volume":"135","author":"Dedroog","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.drudis.2023.103806_b0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2022.09.028","article-title":"Stable amorphous solid dispersion of flubendazole with high loading via electrospinning","volume":"351","author":"Becelaere","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2023.103806_b0050","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1021\/acs.molpharmaceut.2c00970","article-title":"Structural modifications of polyethylenimine to control drug loading and release characteristics of amorphous solid dispersions","volume":"20","author":"Kelsall","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.drudis.2023.103806_b0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2019.09.007","article-title":"Crosslinking: an avenue to develop stable amorphous solid dispersion with high drug loading and tailored physical stability","volume":"311","author":"Sahoo","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2023.103806_b0060","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1021\/acs.molpharmaceut.1c00563","article-title":"High-drug-loading amorphous solid dispersions via in situ thermal cross-linking: unraveling the mechanisms of stabilization","volume":"18","author":"Kapourani","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.drudis.2023.103806_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.104030","article-title":"Evaluating PAA\/PVA thermal crosslinking process during the preparation of in-situ high-drug loading amorphous solid dispersions","volume":"79","author":"Kapourani","year":"2023","journal-title":"J Drug Delivery Sci Technol"},{"key":"10.1016\/j.drudis.2023.103806_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121886","article-title":"Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation","volume":"622","author":"Qi","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2023.103806_b0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.apsb.2013.06.007","article-title":"Use of polymer combinations in the preparation of solid dispersions of a thermally unstable drug by hot-melt extrusion","volume":"3","author":"Liu","year":"2013","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.drudis.2023.103806_b0080","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1002\/jps.24137","article-title":"Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects","volume":"103","author":"Prasad","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.drudis.2023.103806_b0085","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11095-015-1823-y","article-title":"Dissolution performance of high drug loading celecoxib amorphous solid dispersions formulated with polymer combinations","volume":"33","author":"Xie","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.drudis.2023.103806_b0090","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/pharmaceutics13050735","article-title":"Exploring the role of surfactants in enhancing drug release from amorphous solid dispersions at higher drug loadings","volume":"13","author":"Saboo","year":"2021","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.drudis.2023.103806_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122120","article-title":"Role of surfactants in improving release from higher drug loading amorphous solid dispersions","volume":"625","author":"Correa-Soto","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2023.103806_b0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11095-022-03183-4","article-title":"Role of surfactants on release performance of amorphous solid dispersions of ritonavir and copovidone","volume":"39","author":"Indulkar","year":"2022","journal-title":"Pharm Res"},{"key":"10.1016\/j.drudis.2023.103806_b0105","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2017.04.031","article-title":"Surface modification of acetaminophen particles by atomic layer deposition","volume":"525","author":"K\u00e4\u00e4ri\u00e4inen","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2023.103806_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121747","article-title":"Surface nanocoating of high drug-loading spray-dried amorphous solid dispersions by atomic layer coating: excellent physical stability under accelerated storage conditions for two years","volume":"620","author":"Van Duong","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2023.103806_b0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.micromeso.2009.10.026","article-title":"Aging behavior of pharmaceutical formulations of itraconazole on SBA-15 ordered mesoporous silica carrier material","volume":"130","author":"Mellaerts","year":"2010","journal-title":"Microporous Mesoporous Mater"},{"issue":"16","key":"10.1016\/j.drudis.2023.103806_b0120","doi-asserted-by":"crossref","first-page":"8652","DOI":"10.1021\/jp5123008","article-title":"NMR study of BA\/FBA cocrystal confined within mesoporous silica nanoparticles employing thermal solid phase transformation","volume":"119","author":"Skorupska","year":"2015","journal-title":"J Phys Chem C"},{"key":"10.1016\/j.drudis.2023.103806_b0125","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1021\/mp400670f","article-title":"Ibuprofen in mesopores of mobile crystalline material 41 (MCM-41): a deeper understanding","volume":"11","author":"Skorupska","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.drudis.2023.103806_b0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejpb.2023.05.019","article-title":"The processes behind drug loading and release in porous drug delivery systems","volume":"189","author":"Farzan","year":"2023","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.drudis.2023.103806_b0135","article-title":"Mesoporous silica as a carrier for amorphous solid dispersion","author":"Chaudhari","year":"2017","journal-title":"arXiv"},{"key":"10.1016\/j.drudis.2023.103806_b0140","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1039\/b804266g","article-title":"Stabilization of the amorphous state of pharmaceuticals in nanopores","volume":"18","author":"Rengarajan","year":"2008","journal-title":"J Mater Chem"},{"key":"10.1016\/j.drudis.2023.103806_b0145","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1021\/acs.molpharmaceut.0c00811","article-title":"Ternary amorphous solid dispersions containing a high-viscosity polymer and mesoporous silica enhance dissolution performance","volume":"18","author":"Hanada","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.drudis.2023.103806_b0150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/pharmaceutics14020428","article-title":"Superiority of mesoporous silica-based amorphous formulations over spray-dried solid dispersions","volume":"14","author":"Zhang","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.drudis.2023.103806_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104485","article-title":"Entrapment of celecoxib into mesoporous silica particles for tablets with improved dissolution through amorphization","volume":"84","author":"Kim","year":"2023","journal-title":"J Drug Delivery Sci Technol"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644623003227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644623003227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:11:00Z","timestamp":1761225060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644623003227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1359644623003227"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2023.103806","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation strategies for the development of high drug-loaded amorphous solid dispersions","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2023.103806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103806"}}